Translator Disclaimer
1 August 2001 ANTI-cancer Activities of Hypericin in the Dark
Michael Blank, Mathilda Mandel, Sadick Hazan, Yona Keisari, Gad Lavie
Author Affiliations +
Abstract

The potent photodynamic properties of hypericin (HY) elicit a range of light-dependent virucidal and tumoricidal activities. Yet, a relatively low reduction/oxidation potential endows HY with electron accepting and donating properties enabling it to act as both an oxidizing and a reducing agent. HY can thus compete as an electron acceptor from bioenergized reduction/oxidation reactions generating its excitation energy for biological activities from physiological reduction/oxidation reactions in the absence of light. Our studies show that HY can inhibit the growth of highly metastatic murine breast adenocarcinoma and squamous cell carcinoma tumors in culture. Furthermore, we show that HY can interfere with the growth of these tumors in mice reducing tumor size and prolonging animal survival in complete absence of light. While there is no evidence that HY induces apoptosis in these cells in the dark, 3H-thymidine incorporation into DNA was significantly reduced indicating effects that are apparently cytostatic in nature compared to the cytocidal effects of HY with light.

Michael Blank, Mathilda Mandel, Sadick Hazan, Yona Keisari, and Gad Lavie "ANTI-cancer Activities of Hypericin in the Dark," Photochemistry and Photobiology 74(2), 120-125, (1 August 2001). https://doi.org/10.1562/0031-8655(2001)074<0120:ACAOHI>2.0.CO;2
Received: 18 January 2001; Accepted: 1 May 2001; Published: 1 August 2001
JOURNAL ARTICLE
6 PAGES

This article is only available to subscribers.
It is not available for individual sale.
+ SAVE TO MY LIBRARY

SHARE
ARTICLE IMPACT
RIGHTS & PERMISSIONS
Get copyright permission
Back to Top